Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-14-043609
Filing Date
2014-11-26
Accepted
2014-11-26 16:11:14
Documents
1
Period of Report
2014-11-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 3687
  Complete submission text file 0001140361-14-043609.txt   5073
Mailing Address C/O ULTRAGENYX PHARMACEUTICAL INC. 60 LEVERONI COURT, SUITE 200 NOVATO CA 94949
Business Address
Fust Matthew K (Reporting) CIK: 0001397266 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36668 | Film No.: 141253789

Mailing Address 2055 WOODSIDE ROAD SUITE 270 REDWOOD CITY CA 94061
Business Address 2055 WOODSIDE ROAD SUITE 270 REDWOOD CITY CA 94061 650 421 7200
Dermira, Inc. (Issuer) CIK: 0001557883 (see all company filings)

EIN.: 273267680 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations